J Jarvis
Overview
Explore the profile of J Jarvis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jarvis J, Lebedev V, Romanov A, Broemmelsiek D, Carlson K, Chattopadhyay S, et al.
Nature
. 2022 Aug;
608(7922):287-292.
PMID: 35948709
Particle accelerators and storage rings have been transformative instruments of discovery, and, for many applications, innovations in particle-beam cooling have been a principal driver of that success. Stochastic cooling (SC),...
2.
Armstrong R, Baltzopoulos V, Langan-Evans C, Clark D, Jarvis J, Stewart C, et al.
Eur J Appl Physiol
. 2022 Jan;
122(3):769-779.
PMID: 35038023
Purpose: The force-velocity relationship of muscular contraction has been extensively studied. However, previous research has focussed either on isolated muscle or single-joint movements, whereas human movement consists of multi-joint movements...
3.
Crasto W, Morrison A, Gray L, John E, Jarvis J, Brela J, et al.
Diabet Med
. 2019 Sep;
37(2):286-297.
PMID: 31505051
Aims: The Microalbuminuria Education Medication and Optimisation (MEMO) study, revealed improved cardiovascular risk and glycaemic control with 18 months of intensive multifactorial intervention in high-risk people with type 2 diabetes,...
4.
Setty S, Crasto W, Jarvis J, Khunti K, Davies M
Postgrad Med J
. 2016 Feb;
92(1085):152-64.
PMID: 26842973
The legacy effect of early good glycaemic control in people with diabetes shows it is associated with reduction of microvascular and macrovascular complications. Insulin therapy is essential and lifesaving in...
5.
Jarvis J, Seed M, Stocks S, Agius R
Occup Med (Lond)
. 2015 Jul;
65(8):659-66.
PMID: 26209225
Background: A previously developed quantitative structure-activity relationship (QSAR) model has been extern ally validated as a good predictor of chemical asthma hazard (sensitivity: 79-86%, specificity: 93-99%). Aims: To develop and...
6.
Webb D, Khunti K, Chatterjee S, Jarvis J, Davies M
J Diabetes Res
. 2013 May;
2013:561016.
PMID: 23671875
Aims. Adipocytokines are implicated in the pathogenesis of type 2 diabetes and may represent identifiable precursors of metabolic disease within high-risk groups. We investigated adiponectin, leptin, and TNF- α and...
7.
Bicanic T, Ogden D, Whitney L, Loyse A, Jarvis J
HIV Med
. 2012 Oct;
13(10):636-7.
PMID: 23051823
No abstract available.
8.
Cowley N, Laitenberger P, Liu B, Jarvis J, Clutton-Brock T
Anaesthesia
. 2012 Apr;
67(8):870-4.
PMID: 22506665
We report laboratory and clinical evaluations of a blood propofol concentration analyser. Laboratory experiments used volunteer blood spiked with known propofol concentrations over the clinically relevant concentrations from 0.5 to...
9.
Crasto W, Jarvis J, Khunti K, Skinner T, Gray L, Brela J, et al.
Diabetes Res Clin Pract
. 2011 Jun;
93(3):328-36.
PMID: 21640424
Aims: To determine whether tighter cardiovascular risk factor control with structured education in individuals with type 2 diabetes (T2DM) and microalbuminuria benefits cardiovascular risk factors. Methods: Participants from a multiethnic...
10.
Ranganath L, Taylor A, Shenkin A, Fraser W, Jarvis J, Gallagher J, et al.
J Inherit Metab Dis
. 2011 Feb;
34(3):723-30.
PMID: 21311977
Progress in research into rare diseases is challenging. This paper discusses strategies to identify individuals with the rare genetic disease alkaptonuria (AKU) within the general population. Strategies used included a...